Cargando…

A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations

Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Näsström, Thomas, Ådén, Jörgen, Shibata, Fumina, Andersson, Per Ola, Karlsson, Björn C.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084662/
https://www.ncbi.nlm.nih.gov/pubmed/32120928
http://dx.doi.org/10.3390/ijms21051629
_version_ 1783508773829083136
author Näsström, Thomas
Ådén, Jörgen
Shibata, Fumina
Andersson, Per Ola
Karlsson, Björn C.G.
author_facet Näsström, Thomas
Ådén, Jörgen
Shibata, Fumina
Andersson, Per Ola
Karlsson, Björn C.G.
author_sort Näsström, Thomas
collection PubMed
description Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have been limited so far, probably due to the fast aggregation kinetics and burial of aggregation prone segments in final cross-β-sheet fibrils. A previous characterisation study of fibrils prepared from a capped peptide of the non-amyloid β-component (NAC) 71–82 amino acid stretch of α-synuclein demonstrated an increased aggregation propensity resulting in a cross-β-structure that is also found in prion proteins. From this, it was suggested that capped NAC 71–82 peptide oligomers would provide interesting motifs with a capacity to regulate disease development. Here, we demonstrated, from a series of circular dichroism spectroscopic measurements and molecular dynamics simulations, the molecular-environment-sensitive behaviour of the capped NAC 71–82 peptide in a solution phase and the formation of β-sheet oligomeric structures in the supernatant of a fibrillisation mixture. These results highlighted the use of the capped NAC 71–82 peptide as a motif in the preparation of oligomeric β-sheet structures that potentially could be used in therapeutic strategies in the fight against progressive neurodegenerative disorders, such as PD and DLB.
format Online
Article
Text
id pubmed-7084662
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70846622020-03-24 A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations Näsström, Thomas Ådén, Jörgen Shibata, Fumina Andersson, Per Ola Karlsson, Björn C.G. Int J Mol Sci Article Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have been limited so far, probably due to the fast aggregation kinetics and burial of aggregation prone segments in final cross-β-sheet fibrils. A previous characterisation study of fibrils prepared from a capped peptide of the non-amyloid β-component (NAC) 71–82 amino acid stretch of α-synuclein demonstrated an increased aggregation propensity resulting in a cross-β-structure that is also found in prion proteins. From this, it was suggested that capped NAC 71–82 peptide oligomers would provide interesting motifs with a capacity to regulate disease development. Here, we demonstrated, from a series of circular dichroism spectroscopic measurements and molecular dynamics simulations, the molecular-environment-sensitive behaviour of the capped NAC 71–82 peptide in a solution phase and the formation of β-sheet oligomeric structures in the supernatant of a fibrillisation mixture. These results highlighted the use of the capped NAC 71–82 peptide as a motif in the preparation of oligomeric β-sheet structures that potentially could be used in therapeutic strategies in the fight against progressive neurodegenerative disorders, such as PD and DLB. MDPI 2020-02-27 /pmc/articles/PMC7084662/ /pubmed/32120928 http://dx.doi.org/10.3390/ijms21051629 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Näsström, Thomas
Ådén, Jörgen
Shibata, Fumina
Andersson, Per Ola
Karlsson, Björn C.G.
A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title_full A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title_fullStr A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title_full_unstemmed A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title_short A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
title_sort capped peptide of the aggregation prone nac 71–82 amino acid stretch of α-synuclein folds into soluble β-sheet oligomers at low and elevated peptide concentrations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084662/
https://www.ncbi.nlm.nih.gov/pubmed/32120928
http://dx.doi.org/10.3390/ijms21051629
work_keys_str_mv AT nasstromthomas acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT adenjorgen acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT shibatafumina acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT anderssonperola acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT karlssonbjorncg acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT nasstromthomas cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT adenjorgen cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT shibatafumina cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT anderssonperola cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations
AT karlssonbjorncg cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations